Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergothioneine for Mild Cognitive Impairment
NCT03641404Phase 2Completed
- Sponsor
- National University Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ergothioneine in Mild Cognitive Impairment (MCI), sponsored by National University Hospital. Started Aug 2019; status: completed.
02
Drugs
ergothioneine
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT03641404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03641404.